CHI's Structure-Based Drug Design
Predicting Biological and Kinetic Profiles from Structure
| Type | Conference |
|---|---|
| Language | English |
| Date |
June 6, 2012
to June 8, 2012 |
| Venue |
Royal Sonesta Hotel Boston 40 Edwin Land Blvd. Cambridge, MA 02142 US |
| Chemistry Specialties |
|
| Chemistry Techniques |
|
| Contact |
James Prudhomme Cambridge Healthtech Institute 250 First Avenue, Suite 300 Needham, MA 02494 US 781-972-5400 781-972-5425 reg@healthtech.com |
| Add event to calendar |
|
Given the crisis facing the pharmaceutical industry in the translation of early stage drug discovery results, a different set of tools, concerned with algorithms and methods for developing best in class drugs that engage biological targets with kinetically optimized potency and selectivity will need to be refined. In this conference, we bring to focus recent advancements in this field from an experienced faculty. Keynote Address: Binding Kinetics in Drug Discovery David Swinney, Ph.D., CEO, Institute for Rare and Neglected Diseases Drug Discovery (iRND3)
Sponsors
Speakers
Keynote Address:
Binding Kinetics in Drug Discovery
David Swinney, Ph.D., CEO, Institute for Rare and Neglected Diseases Drug Discovery (iRND3)
Session titles
Themed Sessions:
* Sructure to Function
* Free Energy Calculation and Molecular Dynamics Simulation
* GPCR
* Fragment-Based Design
* Druggability and Kinetics-Based Drug Design
* Trends and Advances
